mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.
The Role of Monoclonal Antibodies & Biosimilars in Life Science Research

mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.
Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.
CELLvo™ Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes cultured on CELLvo™ Matrix Plus. Achieve maturation in 7 days.
The human leukocyte antigen system, aka human major histocompatibility complex, was named after its discovery with alloantibodies against leukocytes.
LeadGene ELISA kits to quantitatively detect residual protease in samples.
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
This white paper details findings in molecular mechanisms that govern necroptosis related to RIPK & details #2283 use to analyse expression of RIPK3.
ProSci has 25+ years expertise in developing antibodies. This white paper details use of RIPK antibodies & findings on RIPKs in signalling pathways.
ProSci details the importance of PD-1 antibodies are important in resolving complex interactions between the immune system & pathological conditions.
MBLI offers Assay/Inhibitor screening kits designed to measure the activities of purified kinase for the rapid and sensitive evaluation of inhibitors.